BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial

  July 13, 2026

   · 

  4 min read
• Press Releases

  Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment

  July 13, 2026

   · 

  1 min read
• 

  Huntington’s disease

  Exit of Roche’s embattled Huntington’s drug ‘tightens’ case for Wave’s more selective ASO

  The failure of Roche’s Ionis-partnered tominersen in Huntington’s disease may indicate that Wave Life Sciences’ allele-specific antisense oligonucleotide candidate WVE-003 is on the right track, according to analysts at Rodman & Renshaw.

  July 13, 2026

   · 

  4 min read

   · 

  Heather McKenzie
• Press Releases

  Novartis receives Health Canada approval for VANRAFIA™ (atrasentan tablet) for proteinuria reduction in adults with primary immunoglobulin A nephropathy (IgAN)

  July 13, 2026

   · 

  2 min read
• Press Releases

  BioHarvest Sciences to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC

  July 13, 2026

   · 

  2 min read
• Press Releases

  A.forall Announces ANDA Approval for Sodium Bicarbonate for Injection, USP

  July 13, 2026

   · 

  1 min read
• Press Releases

  MBX Biosciences Announces Executive Leadership Transition to Support the Company’s Next Phase of Growth

  July 13, 2026

   · 

  7 min read
• Press Releases

  Erasca Announces Proposed Public Offering of $500 Million of Common Stock

  July 13, 2026

   · 

  4 min read
• Press Releases

  Tarsus Pharmaceuticals Announces Executive Leadership Transition as Company Advances Next Phase of Growth

  July 13, 2026

   · 

  4 min read
• Press Releases

  Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth

  July 13, 2026

   · 

  8 min read